Latest news with #ElliotIsaacs
Miami Herald
12-06-2025
- Business
- Miami Herald
L'Oréal acquires majority stake in popular British skincare brand
Aging is a privilege, but I work really hard to make sure that my skin doesn't show off that privilege. I spend an absurd amount of money on skincare products. But it's just a tiny contribution toward the $26 billion in sales projected this year for the skincare industry. Don't miss the move: Subscribe to TheStreet's free daily newsletter I have my favorites among the legacy brands sold in drugstores and department stores, but I'm often swayed by newer brands I see on Instagram. Every day, I scroll through a parade of serums, creams, and more that promise to firm, lift, tighten, and moisturize my skin. I click "buy" more than I care to admit, especially if there's scientific evidence that it works (and even if the science goes over my head). The ever-growing popularity of #SkinTok has prompted some legacy brands to work a bit harder to stand out among the sea of skincare competitors, especially when it comes to capturing the attention of Gen Z, which craves clean beauty products. Related: Ulta Beauty issues stern warning as consumers switch gears According to a report by Revieve, an AI-powered beauty and wellness tech company, 56% of Gen Z want fragrance-free beauty, and 33% want to ditch the parabens. Vegan beauty and skincare options? Yes, please. Legacy skincare is listening. One of my all-time favorite brands just made a major move to ensure that the younger generation is "worth it" by increasing its portfolio of science-backed skincare. Legacy beauty brand L'Oréal (LRLCY) has announced that it signed an agreement for the acquisition of a majority stake in Medik8, a British skincare brand. The deal was for an undisclosed sum, although reports suggest the deal is valued at around $1.1 billion. European mid-market private equity firm Inflexion will stay on as a minority stakeholder. Medik8 sales were in the ballpark of $70 to $80 million in 2024, as reported by Business of Fashion, even without a presence in Sephora or Ulta. The brand will be joining the Luxe Division at L'Oréal, which currently houses premium skincare brands including Kiehl's, Youth to the People, and Aesop. "We are delighted to welcome Medik8 to the L'Oréal family. As a premium skincare range, with high levels of proven efficacy at an accessible price point, Medik8 perfectly complements our existing skincare portfolio," said L'Oréal Luxe President Cyril Chapuy in a statement. "We share a strong belief in Medik8's global potential and are excited to embark on this journey together, to build a powerful and impactful brand presence worldwide," he added. Related: Drunk Elephant beauty brand suffers sales drop amid big shakeup Medik8, founded by scientist Elliot Isaacs, is backed by scientific research and innovation. Its premium skincare products include the best-selling Crystal Retinal Serum and its Liquid Peptides Advanced MP Face Serum (the latter was currently sold out on the Medik8 site at the time of this writing). Nearly all its products are developed and manufactured in the ISO-certified Innovation Center just outside of London. Certain generations need no introduction to L'Oréal. The famous L'Oréal Paris tagline "Because you're worth it" likely echoes in many Boomers', Gen Xers', and Millennials' brains. But Gen Z? Unless it's on Instagram or #SkinTok, where products are being hawked by favorite celebrities and influencers with a direct link to buy, even legacy cosmetic brands can find themselves lost amid a sea of products. That's where science-backed Medik8 comes in. Aside from getting the nod by dermatologists and beauty editors, celebrities like Hailey Bieber and Rosie Huntingon-Whiteley are known to use Medik8 products as part of their skincare routines - specifically, the Medik8's R-Retinoate Cream. More in Beauty: Low-cost beauty brand to raise prices due to tariffs, inflationAnother giant cosmetics brand closing store unexpectedlyBankrupt beauty brand to return after $1 billion collapse Although Bieber is the founder and creative director of Rhode - the company recently purchased by E.l.f. Cosmetics - she is a Medik8 fan. And she has over 55 million followers on Instagram and nearly 16 million on TikTok, many of whom are likely eager to replicate her glowing complexion. It's worth noting that Bieber's social media stats alone eclipse the follower counts of both L'Oréal and Medik8 many times over. "This is an exciting day for Medik8," said Medik8 CEO Simon Coble. "I am delighted to be joining forces with a company which shares our vision for the brand's future growth and whose core values align with our deep commitment to science, innovation and above all, results without compromise. I look forward to the next stage in Medik8's journey, as we work together to bring our innovative products to a wider audience." L'Oréal's acquisition of Medik8 will likely be completed in the next few months, pending regulatory approvals and other conditions. Related: Sephora unveils new brand partnership Gen Z will love The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.
Yahoo
10-06-2025
- Business
- Yahoo
L'Oréal to acquire majority stake in British skincare brand Medik8
L'Oréal Group has signed an agreement to acquire a majority stake in UK-based skincare brand Medik8. Inflexion, a European mid-market private equity company, will retain a minority share post-transaction. The acquisition is a strategic move by L'Oréal to bolster its Luxe division with a brand that has a strong foundation in scientific research and innovation. Medik8's performance and potential for international expansion make it a valuable addition to L'Oréal's portfolio. L'Oréal will begin to consolidate Medik8's sales following the transaction's closure. The agreement grants L'Oréal rights to eventually acquire the remaining shares held by minority shareholders. L'Oréal LUXE president Cyril Chapuy stated: 'We are delighted to welcome Medik8 to the L'Oréal family. As a premium skincare range, with high levels of proven efficacy at an accessible price point, Medik8 perfectly complements our existing skincare portfolio. 'We share a strong belief in Medik8's global potential and are excited to embark on this journey together, to build a powerful and impactful brand presence worldwide.' Completion of the transaction is anticipated in the summer or early autumn of 2025, pending regulatory approvals. Founded by scientist Elliot Isaacs, Medik8 is known for its CSA Philosophy: Vitamin C plus Sunscreen by day, Vitamin A by night. Medik8's has expanded its omni-channel sales strategy to include major online and offline retailers in Europe and the US. Medik8 CEO Simon Coble stated: 'I am delighted to be joining forces with a company which shares our vision for the brand's future growth and whose core values align with our deep commitment to science, innovation and above all, results without compromise. I look forward to the next stage in Medik8's journey, as we work together to bring our innovative products to a wider audience.' "L'Oréal to acquire majority stake in British skincare brand Medik8" was originally created and published by Retail Insight Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business of Fashion
09-06-2025
- Business
- Business of Fashion
L'Oréal to Acquire British Skincare Brand Medik8
L'Oréal has acquired a majority stake in British skincare brand Medik8, the companies announced Monday. The brand will be managed under the beauty giant's Luxe division, sitting alongside premium lines like Aesop and Kiehl's. The terms of the transaction were not disclosed, though a recent report in the Financial Times said the brand was valued at roughly $1 billion. Medik8, which was founded in 2009 by Elliot Isaacs, sells science-backed serums that are designed to preserve and restore skin, including its popular Liquid Peptides ($66) and Crystal Retinal ($85) ranges. It has a production and research facility in Buckinghamshire, England, where it manufactures its products. In 2021, Medik8 was acquired by private equity firm Inflexion. Sales reached $70 million to $80 million in 2024, following a push into the US market. Science-backed skincare has been a boon for L'Oréal, which also owns other 'dermocosmetics' brands like the mass lines Cerave and La Roche Posay, as well prestige names like Skinceuticals and Skinbetter Science. 'We share a strong belief in Medik8's global potential,' said Cyril Chapuy, president of L'Oréal Luxe, in a statement. Sign up to The Business of Beauty newsletter, your complimentary, must-read source for the day's most important beauty and wellness news and analysis. Beauty's Top M&A Targets for 2025 After a slow year for acquisitions, brands and investors alike are hoping that 2025 will yield bigger exits. But with most strategic buyers like L'Oréal operating with an even narrower lens, only a select few firms will make it across the finish line.
Irish Examiner
09-06-2025
- Business
- Irish Examiner
Because it's worth it: L'Oreal to buy skincare brand Medik8 in €1bn deal
L'Oreal has agreed to buy a majority stake in the UK company Medik8 as the French cosmetics group strengthens its presence in the booming skincare market. The private equity firm Inflexion will keep a minority stake as part of the deal while the current management will stay on, L'Oreal said on Monday without disclosing financial details. L'Oreal has been boosting its portfolio, seeking to take advantage of the interest in skincare driven by social media influencers who use and promote creams and serums on platforms like TikTok. The Financial Times reported last week that the deal was worth roughly €1bn. L'Oreal shares fell less than 1% in early Paris trading. They have rebounded about 11% so far this year after a slowdown in the US and China weighed on the stock in 2024. Medik8, founded in 2009 by Elliot Isaacs and based just north of London, specializes in anti-aging treatments. It will join L'Oreal's luxury division. Inflexion bought Medik8 for an undisclosed amount in 2021. The brand's founder, Mr Isaacs, will remain on the board of Medik8, L'Oreal said. The deal gives L'Oreal a wider offering in skincare at different prices. Medik8 products are typically more affordable than SkinCeuticals, which L'Oreal bought two decades ago and is now part of its dermatological beauty unit. Cyril Chapuy, who heads the group's luxury division, highlighted Medik8's 'accessible price point'. The dermatological beauty unit saw the fastest growth among L'Oreal's four divisions last year. The unit also includes affordable brands like CeraVe and Vichy. The group also bought Australian cosmetics brand Aesop in 2023 to strengthen the luxury division, which is the second-largest in sales after the consumer-products unit. Other well-known L'Oreal brands include mascara maker Maybelline New York and shampoo labels Garnier and Kérastase. The company in April reported stronger-than-expected sales in the first part of the year, led by demand for high-end make-up and perfumes. Bloomberg
Fashion United
05-06-2025
- Business
- Fashion United
L'Oréal eyes Medik8 for one billion euros
French beauty giant L'Oréal is reportedly poised to acquire cosmetics brand Medik8 for one billion euros, the Financial Times reported on Wednesday. Specialising in 'anti-ageing' skincare, Medik8 would sit within L'Oréal's dermatological beauty section alongside brands like La Roche-Posay and Vichy, which saw its revenue increase by 3.5 percent in the first quarter, to 2.1 billion euros. L'Oréal acquired Australian luxury cosmetics brand Aesop in 2023, then valued at 2.5 billion dollars. The French group, which owns brands Garnier, Maybelline and L'Oréal Paris, concluded partnerships the following year with Italian luxury group Prada around the Miu Miu brand and by increasing its stake in the Swiss laboratory Galderma. Medik8's main shareholder since 2021 has been the investment fund Inflexion, which supported the British brand in the launch of a new research centre and in its development in the US, according to its website. Founded in 2009 by Briton Elliot Isaacs, Medik8 has over 300 employees and boasts a 'made in the UK' product range. This article was translated to English using an AI tool. FashionUnited uses AI language tools to speed up translating (news) articles and proofread the translations to improve the end result. This saves our human journalists time they can spend doing research and writing original articles. Articles translated with the help of AI are checked and edited by a human desk editor prior to going online. If you have questions or comments about this process email us at info@
